Harsha Gunawardena

Principal Scientist

Harsha Gunawardena obtained his Ph.D. from Purdue University where his thesis research was carried out in advanced multi-source ion traps to facilitate the manipulation, reactivity (ion parking) of gaseous ions. He was a post-doctoral fellow at the Lineberger comprehensive cancer center, at The University of North Carolina at Chapel Hill, where his research focused on developing and refining quantitative platforms to support investigators in large-scale proteomics studies in the basic sciences to clinical research. He was a co-investigator for the National Cancer Institute’s Clinical Proteomics Tumor Analysis Consortium (CPTAC) and was a member of UNC ENCODE consortium. He has over 100+ research publication and proceedings and 3 patents. His industry career as scientist started at Bayer Health Care providing mass spectrometry and bioanalytical support of plasma-based therapeutics. He later worked at Amgen applying proteomics methods to support biomarker programs in discovery. His current role at Janssen R&D uses mass spectrometry to support discovery and early development programs.

Talks About
#biochemistry #chemical

Preferred Locations
#Northamerica